Search results
2 new COVID variants called 'FLiRT' are spreading in the U.S. What are the symptoms?
TODAY via Yahoo News· 2 days agoThe new "FLiRT" COVID-19 variants, including KP.2, are spreading in the United States. Will there be...
Common diabetes drug lowers SARS-CoV-2 levels, clinical trial finds
Center for Infectious Disease Research and Policy· 2 days agoToday, researchers from the University of Minnesota published evidence that the common diabetes drug...
SARS-CoV-2 vaccine does not increase new-onset seizure risk
Medical Xpress· 5 days agoThere is no risk for new-onset seizure incidence for individuals receiving a severe acute...
What to Know About the 'FLiRT' Variants of COVID-19
Time Magazine· 6 days agoThe COVID-19 lull in the U.S. may soon come to an end, as a new family of SARS-CoV-2 variants—nicknamed “FLiRT” variants—begins to spread ...
Quiz: Can you pass our 9 question test on the latest theories of COVID-19 transmission
KTEP 88.5 El Paso· 6 days agoThe arrival of SARS-CoV-2, the virus responsible for COVID-19, brought a batch of vocabulary into...
COVID-19 Proteins Can Hang Around In The Blood For Up To 14 Months After Infection
IFLScience· 6 days agoThe idea that SARS-CoV-2, the virus behind COVID-19, may be able to persist in the body long after...
A Man Had Covid For 613 Straight Days—and Created a Whole New Mutation
Prevention via Yahoo News· 4 days agoWhen the world first woke up to the seriousness of the COVID-19 pandemic, the SARS-CoV-2 coronavirus...
ESCMID Presenters Make Case for Saliva Samples in Molecular Infectious Disease Testing
GenomeWeb News· 5 days agoSaliva is a promising sample type for molecular diagnostic testing in infectious diseases beyond ...
Scientists tried to give people COVID — and failed
Nature· 5 days agoResearchers deliberately infect participants with SARS-CoV-2 in ‘challenge’ trials — but high levels of immunity complicate efforts to test vaccines and...
Needham & Company LLC Reiterates Buy Rating for Hologic (NASDAQ:HOLX)
ETF DAILY NEWS· 6 hours agoHologic (NASDAQ:HOLX – Get Free Report)‘s stock had its “buy” rating restated by Needham & Company LLC in a research note issued to investors on Friday, Benzinga reports. Needham & Company LLC ...